VSANasdaqServices-Educational ServicesUS GAAP · USD

VisionSys AI Inc

VisionSys AI Inc is a U.S.-listed Cayman Islands holding company focused on brain-machine interaction technologies and AI-enabled software and hardware systems. Its business centers on developing solutions that combine core algorithms, connected devices, and applied AI for healthcare and biotechnology use cases.

Kysy yhtiöstä
Liikevaihto1,0milj. USD
−99,9 %v/v
Liikevoitto (EBIT)−40,0milj. USD
+92,1 %v/v
EBIT-marginaali−3 848,0%
−3 804,8 %-yks.v/v
Nettotulos1 719milj. USD
+392,8 %v/v

Tilikausi 2025 · muutos edellisvuodesta

Kehitys 2020–2025

−1 00001 0002 0003 000milj. USD2020: 1 898 milj. USD2020: EBIT −806 milj. USD20202021: 2 387 milj. USD2021: EBIT −369 milj. USD20212022: 2 468 milj. USD2022: EBIT 93 milj. USD20222023: 1 375 milj. USD2023: EBIT 13 milj. USD20232024: 1 171 milj. USD2024: EBIT −506 milj. USD20242025: 1,0 milj. USD2025: EBIT −40 milj. USD20251,0−40
LiikevaihtoLiikevoitto (EBIT)
Kysy Clarifolta: VisionSys AI Inc

Liiketoiminta

Osuus liikevaihdosta
Brain-machine interaction systems40 %

Core technologies and systems that connect neural or human input with machine interfaces.

AI software platforms25 %

Software and algorithmic tools used to power intelligent decision-making and interaction.

Hardware systems20 %

Related devices and hardware components used alongside the company's software stack.

Healthcare AI solutions15 %

Applied AI products designed for healthcare workflows and clinical-adjacent use cases.

Asiakkaat

The company appears to serve healthcare, biotechnology, and adjacent technology customers that need specialized AI and human-machine interaction tools. Its products are likely purchased by organizations seeking applied systems rather than generic software, which makes technical performance and domain fit especially important.

Healthcare organizations

Buy AI-enabled systems for healthcare applications and operational use cases.

Biotechnology companies

Use intelligent systems and software tools for biotech-related workflows.

Technology and research users

Adopt brain-machine interaction and software-hardware solutions for specialized applications.

Strategia

The company's strategy is centered on building AI-driven brain-machine interaction offerings and applying them to healthcare and biotechnology markets. Its positioning suggests an emphasis on technical differentiation, combining algorithms, software, and hardware to create integrated solutions with domain-specific utility.

Advance brain-machine interaction technologyKeskipitkä aikaväli

This is the core technology platform and the main source of differentiation.

Expand healthcare and biotech use casesKeskipitkä aikaväli

These end markets provide the clearest commercialization path for applied AI tools.

Maintain access to capital marketsLyhyt aikaväli

A U.S. listing supports financing, visibility, and investor access for a specialized technology business.

Maantiede

VisionSys AI Inc is organized as a Cayman Islands company with a principal executive office in Hebei Province, China, while being listed in the United States through ADSs. The available filings indicate a cross-border operating footprint rather than a single-country business, but they do not disclose a revenue geography split.

Riskit

VisionSys AI Inc faces development, commercialization, and regulatory risks typical of early-stage AI and healthtech businesses. Because its products sit at the intersection of software, hardware, and healthcare applications, execution risk and the need for continued technical validation are likely material.

Järjestetty vakavuuden mukaan
MatalaKohtalainenKorkeaMatalaKohtalainenKorkeaVaikutus →Todennäköisyys →Technology execution risk1Commercial adoption risk2Regulatory and compliance risk3Cross-border governance risk4
Vaikutus on riskin vakavuus ja todennäköisyys sen toteutumisen todennäköisyys lähivuosina, molemmat arvioitu yhtiön raporttien perusteella. Numerot vastaavat listaa.
  1. Technology execution riskVaikutus: KorkeaTodennäköisyys: Kohtalainen

    Brain-machine interaction and AI systems require reliable performance and sustained development.

    Kohdistuu: Core product platform

  2. Commercial adoption riskVaikutus: KorkeaTodennäköisyys: Kohtalainen

    Specialized AI products may be difficult to sell without clear proof of value and customer validation.

    Kohdistuu: Healthcare and biotech customers

  3. Regulatory and compliance riskVaikutus: KeskitasoTodennäköisyys: Kohtalainen

    Healthcare-adjacent products can face approval, data, and compliance scrutiny.

    Kohdistuu: AI healthcare solutions

  4. Cross-border governance riskVaikutus: KeskitasoTodennäköisyys: Kohtalainen

    The company is incorporated in the Cayman Islands with operations in China and a U.S. listing.

    Kohdistuu: Corporate structure and reporting

Kysy Clarifolta: VisionSys AI Inc

Kirjanpito

Harkinnanvaraiset erät
Revenue recognition

Future contracts may combine software, hardware, and services with different timing of delivery.

Vaikutus: Can affect timing of reported revenue and margins

Development costs

AI and hardware businesses often face judgment on whether costs are expensed or capitalized.

Vaikutus: Affects operating loss, assets, and amortization

Foreign currency translation

Operations and executive offices are outside the U.S. while the company reports to U.S. investors.

Vaikutus: Can affect reported equity and earnings volatility

Samankaltaisia listattuja yhtiöitä

Julkisesti listattuja yhtiöitä, joilla on samankaltainen liiketoiminta.

Helport AI Ltd

HPAIW · Services-Prepackaged Software

Visionary Holdings Inc.

GVHGF · Services-Educational Services

Lucas GC Ltd

LGCL · Services-Computer Programming, Data Processing, Etc.

Xiao-I Corp

AIXI · Services-Prepackaged Software

VSee Health, Inc

VSEEW · Services-Health Services

Hestia Insight Inc.

HSTA · Services-Management Consulting Services

Päivitetty: 28.9.2026

VisionSys AI Inc (Nasdaq) – Services-Educational Services | Analyysi – Clarifo